DEBORAH COLLURA: Open Payments
NPI 1942217351 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 32 payments from 12 companies in 2025. Trend: 2023 $768 · 2024 $884 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 8 | $221 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Actelion Pharmaceuticals US, Inc. | 2 | $71 |
| Novo Nordisk Inc | 3 | $70 |
| Amgen Inc. | 4 | $68 |
| Boston Scientific Corporation | 3 | $60 |
| AngioDynamics, Inc. | 1 | $43 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: Barostim Neo System, LEQVIO, Kerendia, OPSUMIT, Wegovy, REPATHA, AURYON LASER SYSTEM 100-120 VAC, SAPIEN 3 Ultra RESILIA.
Industry payments across FL — which companies pay providers there.
